The life sciences and pharmaceutical industry faces unique challenges in managing compliance and navigating risks across borders. In this insightful webinar, sponsored by Control Risks, we will delve into some of the most pressing issues impacting the sector today.
Our experts will explore:
- Challenges in Cross-Border Compliance Investigations: Addressing complexities in regulatory requirements and managing multi-jurisdictional risks.
- Combatting Counterfeiting, Theft, and Parallel Import: Strategies for investigations in high-risk jurisdictions.
- Navigating Sanctions: Practical guidance for companies operating in increasingly regulated global markets.
- Regulatory Developments and Enforcement Trends: Insights into anticipated government actions under the new US administration and their implications for compliance.
This session will provide actionable insights and practical strategies for investigators, compliance professionals, and risk managers to safeguard operations in this highly regulated and dynamic sector.
Panel
Ashu Sharma, ACi Executive Committee
Ash Sharma has over 20 years’ experience in investigations and financial crime risk mitigation. Ash presently manages one of two global investigation hubs for Anglo American Plc, a global mining, minerals and extraction company. His team conduct corporate ethics and compliance (including regulatory and financial crime) investigations. Ash has worked in the UK and Asia in regional and group roles for a global bank. There, he headed up an internal fraud risk, background vetting and investigation function, before leading and coordinating global significant investigations for the group. Ash is a Certified Fraud Examiner, Certified Financial Crime Specialist, and Certified Cryptocurrency Investigator.
Philip Annett, Partner, Baker McKenzie
Philip Annett is a partner based in Baker McKenzie’s London office focussing on complex investigations, litigation and compliance matters. He has an in-depth knowledge of working with UK and international regulators and enforcement agencies, having previously been a senior lawyer in the Enforcement Division at the Financial Conduct Authority (FCA) where he led some of the regulator’s highest-profile enforcement cases. He also previously worked in the Bribery and Corruption Division at the Serious Fraud Office.
Martina Rozumberkova, Principal, Control Risks
Martina Rozumberkova is a Principal within Control Risks’ Compliance, Forensics and Intelligence practice in the Americas. She has over 17 years of experience assisting companies with fraud and forensic investigations as well as reviews, assessments, development and implementation of global compliance programs, and internal controls. She advises companies conducting investigations involving the FCPA and helps address regulatory actions with focused expertise assisting the life science industry. She has also led teams conducting regulatory mandated monitorships.
Whitney Potts, Head Global Security Investigations, Novartis International AG (Switzerland)
Sponsored by
